Thyme Care Expands Multidisciplinary Team to Enhance Cancer Survivorship Support
Thyme Care, at the forefront of value-based cancer care, has taken a significant step to enhance its services aimed at cancer survivors. With the ever-rising number of cancer survivors in the United States—currently over 18 million—the company recognizes the importance of comprehensive support throughout an individual's cancer journey. As such, Thyme Care has announced the appointment of Dr. Asma Dilawari and Dr. Nelia Jain, both seasoned professionals in oncology and palliative care, respectively, to lead the way in its survivorship program expansion.
Dr. Dilawari, joining as the medical director of oncology care, brings over 15 years of experience navigating patients through their transition into survivorship. Her insights from her previous tenure at the FDA, combined with a robust background in clinical oncology, will be integral in designing personalized care systems for survivors.
"Survivorship is not just about completing treatment; it encompasses ongoing management of emotional and physical health challenges," Dr. Dilawari stated. "Many survivors face long-term side effects, which calls for tailored support systems that continue to evolve with their immediate needs and long-term goals."
Thyme Care's survivorship program will provide these patients with dedicated clinical, emotional, and nutritional support, aiming to bridge significant gaps in the care continuum that often remain unaddressed after active treatment. The goal is to ensure that as survivors move into this new phase of life, they are met with comprehensive counseling and resources to help them maintain their health and well-being.
Alongside Dr. Dilawari, Dr. Jain takes on the role of medical director of palliative care, focusing on scaling up the company’s Enhanced Supportive Care program. Dr. Jain, who has a wealth of experience from her time at Devoted Health and notable institutions like Dana-Farber Cancer Institute, emphasizes the importance of addressing the complete spectrum of patient needs—from acute treatment through to survivorship or end-of-life care.
"The beauty of Thyme Care’s holistic approach is that we are not just treating a patient's illness, but the person as a whole. Our work overlaps all aspects of their health—medical, emotional, and social," Dr. Jain explained. "My focus will be on ensuring that patients receive compassion-driven palliative care throughout every step of their journey."
The expansion of Thyme Care’s multidisciplinary team reflects a broader commitment to raising the standard of cancer care. In addition to enhanced medical support, the organization has bolstered its emotional and social support services by incorporating specialized oncology social workers into the virtual care team. These professionals are equipped to address the psychosocial challenges faced by cancer patients, ensuring they have access to resources that help them manage both the emotional weight of a cancer diagnosis and the practicalities of navigating recovery.
Dr. Julia Frydman, the senior medical director overseeing the clinical team, highlighted the need for this kind of holistic support in modern medical practice. "Our growth represents a palpable shift towards recognizing that managing cancer does not conclude with treatment; in fact, it requires a supportive structure to help patients reintegrate into their daily lives and manage long-lasting impacts on their health."
With strategic appointments of Dr. Dilawari and Dr. Jain—both of whom have longstanding ties to and recognition in the oncology community—Thyme Care is well-equipped to tackle the growing demand for comprehensive cancer care. Their patient-centered approach, combined with an innovative tech-enabled care model, sets a promising precedent for addressing the complex needs of cancer survivors head-on.
As they move forward, Thyme Care continues to embody its mission: to transform care and outcomes for individuals living with cancer, ensuring that every patient receives not only effective treatment but ongoing, compassionate support.
For additional information regarding Thyme Care and their innovative approach to oncology care, visit www.thymecare.com.
Dr. Dilawari, joining as the medical director of oncology care, brings over 15 years of experience navigating patients through their transition into survivorship. Her insights from her previous tenure at the FDA, combined with a robust background in clinical oncology, will be integral in designing personalized care systems for survivors.
"Survivorship is not just about completing treatment; it encompasses ongoing management of emotional and physical health challenges," Dr. Dilawari stated. "Many survivors face long-term side effects, which calls for tailored support systems that continue to evolve with their immediate needs and long-term goals."
Thyme Care's survivorship program will provide these patients with dedicated clinical, emotional, and nutritional support, aiming to bridge significant gaps in the care continuum that often remain unaddressed after active treatment. The goal is to ensure that as survivors move into this new phase of life, they are met with comprehensive counseling and resources to help them maintain their health and well-being.
Alongside Dr. Dilawari, Dr. Jain takes on the role of medical director of palliative care, focusing on scaling up the company’s Enhanced Supportive Care program. Dr. Jain, who has a wealth of experience from her time at Devoted Health and notable institutions like Dana-Farber Cancer Institute, emphasizes the importance of addressing the complete spectrum of patient needs—from acute treatment through to survivorship or end-of-life care.
"The beauty of Thyme Care’s holistic approach is that we are not just treating a patient's illness, but the person as a whole. Our work overlaps all aspects of their health—medical, emotional, and social," Dr. Jain explained. "My focus will be on ensuring that patients receive compassion-driven palliative care throughout every step of their journey."
The expansion of Thyme Care’s multidisciplinary team reflects a broader commitment to raising the standard of cancer care. In addition to enhanced medical support, the organization has bolstered its emotional and social support services by incorporating specialized oncology social workers into the virtual care team. These professionals are equipped to address the psychosocial challenges faced by cancer patients, ensuring they have access to resources that help them manage both the emotional weight of a cancer diagnosis and the practicalities of navigating recovery.
Dr. Julia Frydman, the senior medical director overseeing the clinical team, highlighted the need for this kind of holistic support in modern medical practice. "Our growth represents a palpable shift towards recognizing that managing cancer does not conclude with treatment; in fact, it requires a supportive structure to help patients reintegrate into their daily lives and manage long-lasting impacts on their health."
With strategic appointments of Dr. Dilawari and Dr. Jain—both of whom have longstanding ties to and recognition in the oncology community—Thyme Care is well-equipped to tackle the growing demand for comprehensive cancer care. Their patient-centered approach, combined with an innovative tech-enabled care model, sets a promising precedent for addressing the complex needs of cancer survivors head-on.
As they move forward, Thyme Care continues to embody its mission: to transform care and outcomes for individuals living with cancer, ensuring that every patient receives not only effective treatment but ongoing, compassionate support.
For additional information regarding Thyme Care and their innovative approach to oncology care, visit www.thymecare.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.